US2022340913A1PendingUtilityA1

Microorganisms for the production of adipic acid and other compounds

Assignee: GENOMATICA INCPriority: Mar 27, 2008Filed: Mar 9, 2022Published: Oct 27, 2022
Est. expiryMar 27, 2028(~1.7 yrs left)· nominal 20-yr term from priority
C12P 13/005C12P 17/10C12P 7/44C12N 9/001C12N 9/88C12P 13/02C12N 9/1029C12P 7/62C12N 15/52C12N 9/0006C12N 9/80C12Y 103/01031C12Y 101/01035C12N 9/1096C12N 9/0008C12Y 102/0101C12Y 206/01C12P 13/001C12Y 402/01C12P 7/46
84
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides a non-naturally occurring microbial organism having an adipate, 6-aminocaproic acid or caprolactam pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective adipate, 6-aminocaproic acid or caprolactam pathway. The invention additionally provides a method for producing adipate, 6-aminocaproic acid or caprolactam. The method can include culturing an adipate, 6-aminocaproic acid or caprolactam producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an adipate, 6-aminocaproic acid or caprolactam pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce adipate, 6-aminocaproic acid or caprolactam.

Claims

exact text as granted — not AI-modified
1 - 112 . (canceled) 
     
     
         113 . A non-naturally occurring microbial organism, comprising a microbial organism having an adipate pathway comprising at least one exogenous nucleic acid encoding an adipate pathway enzyme expressed in a sufficient amount to produce adipate, said adipate pathway comprising a 2-ketoadipate reductase, an alpha-hydroxyadipate dehydratase, and a oxidoreductase. 
     
     
         114 . The non-naturally occurring microbial organism of  claim 113 , wherein said microbial organism further comprises an alpha-ketoadipate pathway converting alpha-ketoglutarate to alpha-ketoadipate. 
     
     
         115 . The non-naturally occurring microbial organism of  claim 114 , wherein the alpha-ketoadipate pathway comprises alpha-ketoadipate pathway enzymes selected from the group consisting of a homocitrate synthase, a homoaconitase, and a homoisocitrate dehydrogenase. 
     
     
         116 . The non-naturally occurring microbial organism of  claim 113 , wherein said microbial organism comprises two exogenous nucleic acids each encoding an adipate pathway enzyme. 
     
     
         117 . The non-naturally occurring microbial organism of  claim 113 , wherein said microbial organism comprises three exogenous nucleic acids each encoding an adipate pathway enzyme. 
     
     
         118 . The non-naturally occurring microbial organism of  claim 115 , wherein said microbial organism comprises three exogenous nucleic acids each encoding the alpha-ketoadipate pathway enzymes. 
     
     
         119 . The non-naturally occurring microbial organism of  claim 113 , wherein said at least one exogenous nucleic acid is a heterologous nucleic acid. 
     
     
         120 . The non-naturally occurring microbial organism of  claim 113 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 
     
     
         121 . The non-naturally occurring microbial organism of  claim 113 , wherein said microbial organism is a species of bacteria, yeast or fungus. 
     
     
         122 . The non-naturally occurring microbial organism of  claim 113 , wherein said microbial organism is a species of bacteria selected from the group consisting of  Escherichia coli, Klebsiella oxytoca, Anaerobiospirillum succinicproducens, Actinobacillus succinogenes, Mannheimia succiniproducens, Rhizobium etli, Bacillus subtilis, Corynebacterium glutamicum, Gluconobacter oxydans, Zymomonas mobilis, Lactococcus lactis, Lactobacillus plantarum, Streptomyces coelicolor, Clostridium acetobutylicum, Pseudomonas fluorescens  and  Pseudomonas putida.    
     
     
         123 . The non-naturally occurring microbial organism of  claim 113 , wherein said microbial organism is a species of yeast or fungus selected from the group consisting of  Saccharomyces cerevisiae, Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces marxianus, Aspergillus terreus, Aspergillus niger  and  Pichia pastoris.    
     
     
         124 . The non-naturally occurring microbial organism of  claim 123 , wherein said microbial organism is a species of  Saccharomyces cerevisiae.    
     
     
         125 . A method for producing adipate, comprising culturing the non-naturally occurring microbial organism of  claim 113  under conditions and for a sufficient period of time to produce adipate. 
     
     
         126 . The method of  claim 125 , wherein said non-naturally occurring microbial organism is in a substantially anaerobic culture medium. 
     
     
         127 . The method of  claim 125 , wherein said method further comprises separating the adipate from other components in the culture. 
     
     
         128 . The method of  claim 125 , wherein said separating comprises extraction, continuous liquid-liquid extraction, pervaporation, membrane filtration, membrane separation, reverse osmosis, electrodialysis, distillation, crystallization, centrifugation, extractive filtration, ion exchange chromatography, size exclusion chromatography, absorption chromatography or ultrafiltration.

Join the waitlist — get patent alerts

Track US2022340913A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.